SR One set to deploy $500m fund following GSK spin-out
Simeon George, CEO of life sciences investor SR One, speaks to Unquote about raising its first-time fund, the ongoing importance of its relationship with GSK following its spin-out from the company, and the firm's deal pipeline.
More on GPs
Eurazeo raises €2.8bn in 2020
Amount includes the capital raised by Eurazeo Growth III, which has now collected more than €500m
ICG hires Bridge Valley's life sciences investment team
Allan Marchington, who will become head of ICG life sciences, says the team has a strong pipeline
Eight Roads promotes Cornet to partner
Principal Lucile Cornet joined Eight Roads Ventures as an associate in 2016
CapMan boosts wealth advisory team
Nordic firm has appointed four people across wealth advisory, alternative investment and marketing
Latest News
Sponsor Capital acquires and merges Likeit, Nepton
Merged company will have combined revenues of around €8m in 2020, and employ over 50 staff.
Holland Capital invests in Cards PLM Solutions
Digitalisation and project life cycle management business intends to expand in DACH and Benelux
Sinergia Venture Fund holds €30m first close
Fund invests in pre-series-A and series-A rounds to support the growth of startups operating across a large variety of sectors
Octopus to launch £100m healthcare-focused fund
In conjunction with the announcement, the firm has hired an investment team from TenX Health